8-K: DNA X Sees CEO, CCO Depart; Appoints New Director

DNA X, Inc. announced the resignation of its CEO and CCO, Peter Liu and Charles Becher, respectively, and the appointment of Scott Walker to its Board of Directors.

Summary

• Peter Liu resigned from his position as Chief Executive Officer and as a director on the Board of DNA X, Inc., effective January 30, 2026.
• Mr. Liu's resignation was not a result of any disagreement with the Company.
• Charles Becher resigned from his position as Chief Commercial Officer, effective January 29, 2026.
• Mr. Liu will receive a total cash severance payment of $855,000, representing 150% of his annual base salary and 100% of his target bonus, payable in two tranches: $427,500 within three days of signing the separation agreement and the remaining $427,500 on March 15, 2026.
• Mr. Becher will receive a total lump-sum cash severance payment of $250,000, representing one year of his annual base salary, payable within thirty days of January 29, 2026.
• Both Mr. Liu and Mr. Becher will have all their outstanding and unvested stock options accelerated and deemed fully vested as of their respective separation dates.
• Both departing executives will be reimbursed for six months of COBRA premiums to continue health insurance coverage.
• Scott Walker was appointed to the Board of Directors on January 30, 2026, following Mr. Liu's resignation.
• Mr. Walker's appointment is pursuant to DNA Holdings Venture, Inc.'s right to designate a director, as outlined in the Membership Interest Purchase Agreement, given DNA Holdings beneficially owns at least 5% of the Company.
• Mr. Walker is a beneficial owner and co-founder of DNA Holdings, and his appointment is based on his significant leadership experience and extensive technical expertise in blockchain technology and cryptocurrencies.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative development due to the simultaneous departure of key executives, which can create leadership uncertainty, despite the amicable nature of the resignations and the strategic expertise brought by the new director.

Positives

• The resignations of both the CEO and CCO were stated not to be a result of any disagreement with the Company, suggesting amicable separations.
• The appointment of Scott Walker to the Board brings significant leadership experience and extensive technical expertise in blockchain technology and cryptocurrencies, potentially aligning with future strategic directions.
• The separation agreements ensure an orderly transition and include standard provisions for cooperation and non-disparagement.

Negatives

• The simultaneous departure of the Chief Executive Officer and Chief Commercial Officer, two key leadership positions, could introduce uncertainty and potential disruption to the Company's operations and strategic execution.
• The Company will incur significant severance costs totaling $1,105,000 for the two departing executives.
• The original terms of Peter Liu's severance payment were modified from a lump sum within 30 days to two tranches, with the second tranche delayed until March 15, 2026.

Risks

• Potential for disruption or uncertainty due to the departure of key leadership, which may impact operational stability and strategic direction.
• Integration risk associated with new leadership and board members, particularly in adapting to new strategic priorities.
• Potential for perceived conflicts of interest given Mr. Walker's beneficial ownership in DNA Holdings and the existing DNA Agreements with the Company.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the scheduled payment of severance tranches and the tenure of the newly appointed director.

Management Comments

• "My resignation is not as a result of any disagreement between myself and the Company, its management, the Board, or any committee of the Board." (Peter Liu)
• "I appreciate our partnership and wish the Company continued success." (Peter Liu)
• "I appreciate the opportunity to have been part of the team and wish DNA X continued success." (Charles Becher)

Industry Context

StockSavvy.ai notes that the departure of a CEO and CCO, especially when coupled with a new director appointment tied to a significant investor (DNA Holdings) possessing blockchain and cryptocurrency expertise, suggests a potential strategic pivot towards digital assets or a significant corporate restructuring. This aligns with broader industry trends where traditional companies are increasingly exploring or integrating advanced technological domains.

Comparison to Industry Standards

• Severance packages for departing executives, particularly CEOs, typically include a combination of base salary, bonus, and equity acceleration. Peter Liu's severance of $855,000 (150% of annual base salary plus 100% target bonus), along with accelerated stock options and 6 months of COBRA, appears to be a standard, albeit generous, package for a non-disagreement departure.
• Charles Becher's one-year base salary severance of $250,000, plus accelerated options and COBRA, is also within typical industry norms for a Chief Commercial Officer.
• The appointment of a director designated by a significant shareholder (DNA Holdings) is a common practice in investment agreements, ensuring investor representation and strategic alignment on the board.

Management Changes

Corporate Governance

Related Party Transactions

• Scott Walker is a beneficial owner and co-founder of DNA Holdings Venture, Inc.
• DNA Holdings Venture, Inc. is a party to the Membership Interest Purchase Agreement, Securities Purchase Agreement, and a convertible promissory note in the principal amount of $1,200,000.00 with DNA X, Inc.
• Mr. Walker may be deemed to have an indirect material interest in these DNA Agreements due to his beneficial ownership interest in DNA Holdings.

Stakeholder Impact

• Shareholders: Potential for increased uncertainty due to executive turnover, but also the possibility of a strategic pivot and new expertise on the board. The significant severance payments represent a notable financial outflow.
• Employees: The departure of the CEO and CCO could impact morale and create uncertainty regarding the Company's future leadership and strategic direction.
• Customers/Suppliers: No direct immediate impact mentioned, but leadership changes can sometimes lead to shifts in business strategy or relationships over time.
• Creditors: The convertible promissory note with DNA Holdings indicates a debt obligation, which is a factor for creditors.

Next Steps

• Scott Walker will continue as a director until the next annual meeting of stockholders or until his successor has been elected and qualified, or, if sooner, until his earlier death, resignation or removal.
• The second tranche of Peter Liu's severance payment, amounting to $427,500, is scheduled to be paid on March 15, 2026.

Key Dates

Recommendation

The simultaneous departure of the CEO and CCO introduces significant uncertainty regarding the company's immediate operational stability and strategic direction. While the appointment of Scott Walker, with his blockchain and cryptocurrency expertise, and his connection to DNA Holdings, suggests a potential strategic pivot or strengthening of a new direction, the full implications are not yet clear. The substantial severance packages and the change in payment terms for the former CEO also warrant caution. Investors should hold to observe the company's next leadership appointments and strategic announcements before making further investment decisions.

Keywords

DNA X, Sonim Technologies, CEO resignation, CCO resignation, board appointment, Scott Walker, Peter Liu, Charles Becher, severance agreement, stock options, corporate governance, blockchain, cryptocurrency, DNA Holdings, 8-K filing